It was another big rally taking the Dow to still another record as financials and other value stocks got a boost from news that unemployment claims had fallen 92,000 from the prior week. Though the real proof of the pudding will be Friday’s payrolls report, investors continue to show nothing but optimism in economic recovery. Pharmaceuticals took a bit of a hit from Biden’s proposal to waive vaccine property rights but it didn’t seem to be that big a deal with even Moderna saying it wouldn’t hurt future sales. Volume had still another day a little above average and quite brisk at 11 billion.
THU MAY 6, 2021 4:42 PM
Dow ends at record high after upbeat
jobless claims report
DJ: 34,230.34 +97.31 NAS: 13,582.43 -51.08 S&P: 4,167.59 +2.93 5/5
DJ: 34,548.53 +318.19 NAS: 13,632.84 +50.42 S&P: 4,201.62
+34.03 5/6
(Reuters)
- The Dow Jones Industrial Average closed at a record high on Thursday,
bolstered by an upbeat weekly jobless claims report, while vaccine makers
dipped after U.S. President Joe Biden backed plans to waive patents on COVID-19
shots. Lifted by Apple Inc, the S&P
500 rose after a Labor Department report showed initial claims for state unemployment
benefits totaled a seasonally adjusted 498,000 for the week ended May 1,
compared with 590,000 in the prior week.
Investors
were awaiting a more comprehensive non-farm payrolls report on Friday for clues on the strength of the labor
market and potentially the U.S. Federal Reserve’s stance on monetary policy. “Investors are encouraged by the low-interest
rates and the stimulus that the government is putting into the economy. We’re
also seeing substantial increases in economic projections and earnings
forecasts,” said Sam Stovall, chief investment strategist at CFRA Research.
Pharmaceutical
companies dropped after the White House said Biden made the decision to back a
proposed waiver for COVID-19 vaccine intellectual property rights.
Shares in Pfizer Inc and Moderna Inc fell 1% or more. Johnson &
Johnson and Novavax Inc ended higher after spending much of the day in negative
territory. The Nasdaq biotechnology
index dropped 0.4%. Moderna’s shares cut
some losses after it said countries around the globe would continue buying its
COVID-19 vaccine for years even if patents on the shots are waived.
The S&P 500 financials index was the top performer
among the 11 sectors, gaining
1.4%. “One sector we are seeing a lot of opportunities in is the
financial sector. We see it as one that should benefit from higher
interest rates and a stronger economic recovery,” said Ann Guntli, portfolio
manager at Chicago-based RMB Capital. Microsoft Corp, Apple AAPL.O, Facebook and Amazon.com Inc rose more than
1%.
The
Dow Jones Industrial Average rose 0.93% to end at 34,548.53 points, while the
S&P 500 gained 0.82% to 4,201.62. The
Nasdaq Composite climbed 0.37% to 13,632.84.
In extended trade, Square rose 3% after
the mobile payments company announced a 266% jump in quarterly total net
revenue. During the trading session,
Costco Wholesale jumped 2.75% after the retailer said late on Wednesday that
its April sales surged 33.5%. That rally helped push the S&P 500 consumers
staple index higher. Regeneron
Pharmaceuticals Inc rose 3.37% after the drugmaker reported a
better-than-expected quarterly profit and said it expected demand for its
COVID-19 antibody therapy to hold up. Uber
Technologies Inc tumbled 8.85% after it signaled it would pay drivers more to
get cars back on the road as the pandemic recedes, and disclosed a $600 million
charge to provide UK drivers with benefits.
Advancing issues outnumbered declining
ones on the NYSE by a 1.33-to-1 ratio; on Nasdaq, a 1.38-to-1 ratio favored
decliners. The S&P 500 posted 121
new 52-week highs and no new lows; the Nasdaq Composite recorded 118 new highs
and 155 new lows.
Volume on U.S. exchanges was 11 billion shares, compared with the 10 billion average for the full session over the last 20 trading days.
No comments:
Post a Comment